Polyrizon ltd. announces $17.0 million private placement

Raanana, israel, march 31, 2025 (globe newswire) -- polyrizon ltd. (nasdaq: plrz) (the “company”), a biotech company specializing in innovative intranasal hydrogels, today announced that it has entered into definitive agreements with institutional investors for the purchase and sale of approximately $17.0 million of ordinary shares and/or pre-funded and investor warrants at a price of $0.48 per ordinary unit.
PLRZ Ratings Summary
PLRZ Quant Ranking